Previous 10 | Next 10 |
Amarin ( AMRN ) Q1 results : More news on: Amarin Corporation plc, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Amarin (NASDAQ: AMRN ): Q1 Non-GAAP EPS of -$0.03 beats by $0.04 ; GAAP EPS of -$0.06 beats by $0.01 . More news on: Amarin Corporation plc, Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
Total Revenue Increased 112% to $155 Million in First Quarter 2020 Compared to Prior Year Management to Host Conference Call at 7:30 a.m. ET Today DUBLIN, Ireland and BRIDGEWATER, N.J., April 30, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), today announced fi...
Amarin (NASDAQ: AMRN ) is scheduled to announce Q1 earnings results on Thursday, April 30th, before market open. The consensus EPS Estimate is -$0.07 (-40.0% Y/Y) and the consensus Revenue Estimate is $150.06M (+104.8% Y/Y). Over the last 2 years, AMRN has beaten EPS estimates 75% of...
DUBLIN, Ireland and BRIDGEWATER, N.J., April 28, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with members of Amarin senior management to discuss the company's first quarter 2020 financial results and provide an operationa...
Source : Read more ...
Axsome Therapeutics (NASDAQ: AXSM ) +44% as Avadel Pharmaceuticals gains 34% on positive data on lead drug. More news on: Axsome Therapeutics, Inc., Avadel Pharmaceuticals plc, Yield10 Bioscience, Inc., Stocks on the move, , Read more ...
First, let's be clear about a few things. I do not give advice to readers. I do not suggest readers invest or divest positions with companies that I write about. I do not tout investment advice that I look to sell to readers. I have no agenda when writing. Rather, it is based on interesting si...
Amarin ( AMRN ) is seeking marketing authorization for Vascepa in Europe. If the product is deemed approvable by the European Medicines Agency, marketing authorization should approximately come at the end of 2020. As everyone knows, the Nevada district court found the MARINE patents under ...
The past month was rough for Amarin (AMRN) investors, to say the least. The company didn't receive a favorable ruling in their patent lawsuit against generics Dr. Reddy's (RDY) and Hikma (HKMPF ) in a U.S. District Court. Judge Miranda Du found that the generics infringed on Amarin's patents. ...
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...